Jun 2026
Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark
A new baseline method is developed identifying the critical components to solve the NMO tasks, including a novel representation for modeling structural constraints and a domain-agnostic pretraining strategy to eliminate pharmaceutical dataset bias.
Matthias Blaschke, Daniel Kienzle, Zsuzsanna Koczor-Benda et al.
· arXiv.org · 0 citations